Shandong Sinoglory Health (603182) — Cash Flow Reinvestment Rate
Shandong Sinoglory Health (603182) has a Cash Flow Reinvestment Rate of 1.28x as of December 2024, reinvesting CN¥400.44 Million (capex CN¥399.54 Million plus investments CN¥893.61K) from operating cash flow of CN¥313.81 Million. Explore capital reinvestment ratio of Shandong Sinoglory Health to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Sinoglory Health Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Shandong Sinoglory Health across 5 annual periods. Also explore 603182 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shandong Sinoglory Health (2020–2024)
Year-by-year capital reinvestment analysis for Shandong Sinoglory Health. For live market cap and broader valuation context, see market cap of Shandong Sinoglory Health.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.28x | CN¥400.44 Million | CN¥313.81 Million | CN¥399.54 Million | ▼ -84.4% |
| 2023 | 8.19x | CN¥305.65 Million | CN¥37.34 Million | CN¥154.79 Million | ▲ +650.5% |
| 2022 | 1.09x | CN¥119.07 Million | CN¥109.17 Million | CN¥45.29 Million | ▼ -26.1% |
| 2021 | 1.48x | CN¥63.94 Million | CN¥43.34 Million | CN¥33.70 Million | ▲ +15.1% |
| 2020 | 1.28x | CN¥140.67 Million | CN¥109.73 Million | CN¥71.10 Million | — |